Bayer is suing Watson Pharmaceuticals Inc. (NYSE: WPI | news | PowerRating | PR Charts ) and Sandoz over their applications to market a generic version of Yasmin. In March, the U.S. District Court for the District of New Jersey ruled in favor of Barr and found Bayer's patent on the drug invalid. Bayer has appealed the ruling in the U.S. District Court of Appeals for the Federal Circuit.
Shares of Barr rose rose $1.89, or 4.96 percent, to close at $39.99. The stock has traded between $37.40 and $58.38 over the last 52 weeks. Shares of Watson Pharmaceutical rose eight cents to close at $28.28 Friday.
FinancialWire" is a fully independent, proprietary news wire service of Investrend Information (a division of Investrend Communications, Inc.). FinancialWire" news is written by professional journalists, dedicated to pure journalistic standards. FinancialWire" does not receive or accept any compensation from any individual or subject company (or representative thereof) for its news or opinions. All FinancialWire" news is available at http://www.financialwire.net . Please address any inquiries to feedback@financialwire.net .
Free annual reports for companies mentioned in the news are available at http://investrend.ar.wilink.com/?level=279 .
http://www.financialwire.net
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|
|
